← All trials
NCT05161390
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 30, 2021
- Primary completion
- Mar 10, 2025
- Completion date
- Jun 8, 2025
- First posted
- Dec 17, 2021
- Last posted
- Dec 17, 2021
- Enrollment
- 128
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- LaNova Medicines LimitedLead sponsor
- Nanchang UniversityOverall official - principal investigator
- Fudan UniversityOverall official - principal investigator
- Jiao Tong UniversityOverall official - principal investigator
- Harbin Medical UniversityOverall official - principal investigator
- Huazhong University of Science and TechnologyOverall official - principal investigator
- Shandong Provincal Cancer HospitalOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.